Declan Doogan - Net Worth and Insider Trading

Declan Doogan Net Worth

The estimated net worth of Declan Doogan is at least $21 Million dollars as of 2022-12-06. Declan Doogan is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $21 Million. Details can be seen in Declan Doogan's Latest Holdings Summary section.

Transaction Summary of Declan Doogan

To
Not Enough Data to Display

Declan Doogan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Declan Doogan owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Tenax Therapeutics Inc (TENX) .

Click here to see the complete history of Declan Doogan’s form 4 insider trades.

Insider Ownership Summary of Declan Doogan

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2017-05-03 director
TENX Tenax Therapeutics Inc 2021-02-25 director

Declan Doogan Latest Holdings Summary

Declan Doogan currently owns a total of 1 stock. Declan Doogan owns 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 29, 2021, with a value of $21 Million.

Latest Holdings of Declan Doogan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-29 1,496,650 14.08 21,072,832

Holding Weightings of Declan Doogan


Declan Doogan Form 4 Trading Tracker

According to the SEC Form 4 filings, Declan Doogan has made a total of 15 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 24,525 shares on November 29, 2021, which brought Declan Doogan around $3 Million.

Insider Trading History of Declan Doogan

Ticker Company Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Current Price Price Change Since Insider Trade (%) Filing Date
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-11-29 Sell
24,525.00
-1.61%
$112.80
$2,766,420.00
1,496,650.00
$14.08
-87.52%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-11-16 Sell
37,740.00
-2.42%
$116.65
$4,402,370.00
1,521,175.00
$14.08
-87.93%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-16 Sell
41,306.00
-3.97%
$68.49
$2,829,050.00
999,914.00
$14.08
-79.44%
2022-02-11
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-16 Sell
140,000.00
-12.28%
$67.37
$9,431,800.00
999,915.00
$14.08
-79.10%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-12 Sell
50,953.00
-4.28%
$65.19
$3,321,630.00
1,139,915.00
$14.08
-78.40%
2022-02-11
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-12 Sell
160,000.00
-12.31%
$64.07
$10,251,200.00
1,139,915.00
$14.08
-78.02%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-04-16 Sell
88,825.00
-6.40%
$58.42
$5,189,160.00
1,299,915.00
$14.08
-75.90%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-03-26 Sell
11,175.00
-0.80%
$53.69
$599,986.00
1,388,740.00
$14.08
-73.78%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-03-01 Sell
101,024.00
-6.73%
$46.26
$4,673,370.00
1,399,915.00
$14.08
-69.56%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-02-19 Sell
2,078.00
-0.13%
$45.48
$94,507.40
1,577,837.00
$14.08
-69.04%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-02-13 Sell
40,000.00
-1.46%
$44.31
$1,772,400.00
2,702,075.00
$14.08
-68.22%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-06-05 Sell
89,216.00
-5.10%
$35.25
$3,144,860.00
1,659,915.00
$14.08
-60.06%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-06-01 Sell
110,784.00
-5.96%
$35.03
$3,880,760.00
1,749,131.00
$14.08
-59.81%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-18 Sell
128,058.00
-6.44%
$26.95
$3,451,160.00
1,859,915.00
$14.08
-47.76%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-12 Sell
121,942.00
-9.38%
$26.78
$3,265,610.00
1,178,058.00
$14.08
-47.42%
-
Total 15
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Declan Doogan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Declan Doogan Ownership Network

Ownership Network List of Declan Doogan

No Data

Ownership Network Relation of Declan Doogan


Declan Doogan Owned Company Details


Declan Doogan Mailing Address

Above is the net worth, insider trading, and ownership report for Declan Doogan. You might contact Declan Doogan via mailing address: C/o Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven Ct 06510.